Latest CTIC reports update at 2023-05-15: 2023-Q12022-Q42022-Q1
CTI BioPharma Corp. logo
CTI BioPharma Corp. CTIC
$ 9.09 0.0%

CTI BioPharma Corp. Financial Ratios 2011-2024 | CTIC

Annual Financial Ratios CTI BioPharma Corp.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-5.9 -1.7 -4.5 -1.8 -2.2 -2.7 -2.5 -2.0 -3.5 -8.9 -0.8 -3.0

P/S

10.2 - 56235.3 21.0 2.5 4.4 2.3 14.7 5.4 10.9 - -

EPS

-0.8 -1.1 -0.7 -0.7 -0.5 -1.2 -1.9 -0.7 -0.7 -0.4 -2.0 -0.7

EV (Enterprise Value)

664 M 174 M 214 M 67.4 M 66.1 M 122 M 142 M 206 M 310 M 358 M 75.2 M 174 M

EBITDA per Share

-0.68 -1.05 -0.664 -0.679 -0.564 -1.06 -1.73 -6.14 -5.73 -3.49 -16.9 -20.6

EV/EBITDA

-1.0 -4.3 -1.2 -1.4 -2.5 -2.2 -1.4 -3.2 -8.1 -0.4 -2.0

PEG

4.94 0.95 0.62 0.05 -0.04 -0.08 -0.03 0.94 0.07 -0.11 -0.02 -0.06

P/B

-31.3 45.5 5.9 3.9 1.2 6.8 16.7 5.0 8.5 8.9 2.6 6.7

P/CF

-6.8 -2.0 -5.6 -2.5 -1.6 -2.8 -1.7 -2.5 -8.2 -10.1 -1.3 -3.0

ROE %

529.06 -2599.10 -131.03 -223.20 -55.38 -252.77 -670.48 -251.88 -242.65 -99.96 -307.72 -222.64

ROA %

-73.85 -135.17 -90.06 -86.47 -32.64 -74.10 -81.46 -82.74 -101.17 -45.61 -137.53 -100.19

ROCE %

453.99 -2530.71 -115.94 -143.63 -48.28 -110.92 -211.93 -162.21 -154.13 -56.17 -196.99 -164.64

Current Ratio

0.9 1.1 3.2 1.9 3.6 2.4 1.4 1.9 2.2 4.0 2.7 2.9

DSO

52.1 - - - 189.9 18.6 51.9 6.4 12.2 2.5 - -

DIO

38.1 - - - - 551.5 404.2 535.3 1705.5 13518.3 - -

DPO

306.4 - - - 1867.8 2595.1 1915.7 1991.3 2592.1 13457.0 - -

Operating Cycle

90.1 - - - 189.9 570.1 456.1 541.7 1717.7 13520.8 - -

Cash Conversion Cycle

-216.2 - - - -1677.9 -2025.0 -1459.6 -1449.7 -874.4 63.8 - -

All numbers in USD currency

Quarterly Financial Ratios CTI BioPharma Corp.

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.1 - -0.13 -0.21 -0.37 - -0.26 -0.21 -0.23 - -0.15 -0.19 -0.2 - -0.17 -0.19 -0.19 - -0.26 -0.2 -0.08 -0.33 -0.28 0.03 -0.71 -0.23 -1.04 -0.71 0.12 -0.13 -0.19 -0.19 -0.16 -0.27 0.03 -0.19 -0.2 0.08 -0.2 -0.17 -0.18 -0.2 -0.38 -1.38 -0.43 -0.47 -0.8 -0.14 -0.35

EBITDA per Share

-0.07 - -0.09 -0.17 -0.35 - -0.24 -0.21 -0.22 - -0.14 -0.13 -0.19 - -0.16 -0.18 -0.18 - -0.25 -0.24 -0.08 - -0.26 0.18 -0.68 - -1 -0.67 0.16 - -0.18 -0.17 -0.16 - 0.06 -0.18 -0.19 - -0.13 -158 -0.17 -0.17 -0.25 -1.14 -0.43 -0.24 -0.37 -0.1 -0.1

ROE %

669.05 655.98 593.80 438.35 -23.07 -158.84 -182.90 -144.78 -147.87 -89.47 -131.89 -150.25 -161.59 -134.38 -159.61 -142.43 -115.43 -51.40 -116.80 -146.46 -102.40 -186.45 -168.89 -333.10 -506.25 -390.49 -391.92 -235.45 -149.69 -229.52 -279.80 -206.14 -209.11 -223.61 -101.48 -146.91 -121.17 -94.62 -171.03 -180.58 -285.81 -293.40 -270.79 -284.85 -198.93 -217.15 -58.02 -59.19 -68.72

ROA %

-54.23 -57.84 -81.73 -92.89 -101.44 -89.63 -108.96 -104.42 -103.07 -64.30 -86.01 -88.38 -88.05 -68.78 -85.27 -80.04 -68.96 -33.58 -59.57 -64.90 -42.45 -74.10 -58.09 -81.98 -122.78 -81.46 -89.26 -66.15 -57.80 -82.82 -110.08 -82.49 -89.58 -101.17 -45.25 -66.82 -56.35 -45.61 -81.72 -85.74 -134.54 -137.53 -126.70 -132.86 -92.16 -100.19 -26.77 -27.31 -31.71

ROCE %

539.59 556.34 496.21 363.52 -26.13 -155.78 -179.37 -142.84 -136.20 -78.37 -119.37 -136.78 -158.21 -131.87 -157.03 -141.20 -118.64 -56.41 -110.35 -139.13 -91.11 -118.35 -333.56 -494.83 -662.15 -327.38 -388.79 -234.99 -151.47 -173.86 -155.97 -76.66 -80.90 -112.22 -146.50 -198.68 -174.33 -114.80 -169.36 -178.92 -282.37 -293.75 -273.71 -283.11 -199.05 -216.56 -53.24 -58.92 -69.89

Current Ratio

0.8 0.9 0.9 1.0 0.8 1.1 1.6 4.9 2.6 3.2 3.2 3.2 3.2 1.6 1.6 1.6 1.6 2.4 2.4 2.4 2.4 1.4 1.4 1.4 1.4 1.1 1.1 1.1 1.1 1.5 1.5 1.5 1.5 1.8 1.8 1.8 1.8 2.5 2.5 2.5 2.5 2.7 2.7 2.7 2.7 3.0 3.0 3.0 3.0

DSO

72.5 - 46.9 39.2 48.2 - - - - - - - - - - - - - - - 0.0 18.2 17.7 1.0 23.1 3.8 7.8 4.7 0.8 2.3 26.7 23.4 38.4 10.3 4.6 136.6 72.6 0.7 59.2 70.1 9.5 - - - - - - - -

DIO

56.3 - 73.2 40.0 16.7 - - - - - - - - - - - - - - 43.8 - - 761.1 643.4 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

150.3 - 219.4 274.8 1036.6 - - - - - - - - - - - - - 3600.4 698.0 - - 3422.5 3027.6 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

128.8 - 120.1 79.2 65.0 - - - - - - - - - - - - - - 43.8 0.0 18.2 778.7 644.4 23.1 3.8 7.8 4.7 0.8 2.3 26.7 23.4 38.4 10.3 4.6 136.6 72.6 0.7 59.2 70.1 9.5 - - - - - - - -

Cash Conversion Cycle

-21.5 - -99.3 -195.6 -971.6 - - - - - - - - - - - - - -3600.4 -654.3 0.0 18.2 -2643.8 -2383.2 23.1 3.8 7.8 4.7 0.8 2.3 26.7 23.4 38.4 10.3 4.6 136.6 72.6 0.7 59.2 70.1 9.5 - - - - - - - -

All numbers in USD currency